全文获取类型
收费全文 | 7938篇 |
免费 | 734篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 123篇 |
儿科学 | 238篇 |
妇产科学 | 174篇 |
基础医学 | 969篇 |
口腔科学 | 328篇 |
临床医学 | 860篇 |
内科学 | 1562篇 |
皮肤病学 | 237篇 |
神经病学 | 490篇 |
特种医学 | 575篇 |
外科学 | 1272篇 |
综合类 | 218篇 |
一般理论 | 8篇 |
预防医学 | 724篇 |
眼科学 | 64篇 |
药学 | 516篇 |
1篇 | |
中国医学 | 5篇 |
肿瘤学 | 325篇 |
出版年
2021年 | 106篇 |
2020年 | 68篇 |
2019年 | 124篇 |
2018年 | 112篇 |
2017年 | 86篇 |
2016年 | 114篇 |
2015年 | 126篇 |
2014年 | 180篇 |
2013年 | 265篇 |
2012年 | 317篇 |
2011年 | 306篇 |
2010年 | 207篇 |
2009年 | 197篇 |
2008年 | 259篇 |
2007年 | 279篇 |
2006年 | 337篇 |
2005年 | 296篇 |
2004年 | 245篇 |
2003年 | 280篇 |
2002年 | 243篇 |
2001年 | 222篇 |
2000年 | 238篇 |
1999年 | 217篇 |
1998年 | 159篇 |
1997年 | 152篇 |
1996年 | 147篇 |
1995年 | 129篇 |
1994年 | 86篇 |
1993年 | 110篇 |
1992年 | 173篇 |
1991年 | 173篇 |
1990年 | 172篇 |
1989年 | 211篇 |
1988年 | 184篇 |
1987年 | 170篇 |
1986年 | 184篇 |
1985年 | 204篇 |
1984年 | 145篇 |
1983年 | 96篇 |
1982年 | 85篇 |
1981年 | 88篇 |
1980年 | 74篇 |
1979年 | 86篇 |
1978年 | 92篇 |
1977年 | 82篇 |
1976年 | 79篇 |
1975年 | 66篇 |
1974年 | 62篇 |
1973年 | 76篇 |
1970年 | 56篇 |
排序方式: 共有8689条查询结果,搜索用时 297 毫秒
11.
RA O. Hempel 《Notfall & Rettungsmedizin》2007,10(5):367-371
Legal uncertainties for emergency vehicle drivers can be avoided when fundamental rules are established. In particular, differentiation of special rights and rights of way is essential. Inherent in both is the urgency necessary to save human lives. The right of way signaled by flashing blue lights and siren does not however justify traffic violations but signifies rather a request to other traffic participants. In contrast, special rights require no announcement and constitute a justifiable reason for traffic violations. Even so they do not allow that other traffic participants be endangered or harmed. Adherence to these basic principles can prevent legal misinterpretations as well as rigid adoption of inflexible standards of behavior. 相似文献
12.
RA Mag. Dr. C. Gepart 《Notfall & Rettungsmedizin》2007,10(4):289-292
Austria’s new Living Wills Act (Patientenverfügungsgesetz, or PatVG) that came into effect on 1st of June 2006, is the first law in Austria to regulate the controversial issue of living wills. The PatVG provides for a right to refuse future medical treatment by making an advance directive in the form of a living will that is either binding or “to be taken into consideration”. However, the establishment of a binding living will is governed by strict criteria as regards form and content, and both a medical doctor and a legal expert must be involved. Compliance with a living will is not allowed where there is a legal obligation to give medical treatment. There is also a legal obligation to give medical treatment in emergency situations where the time involved in looking for a living will could seriously endanger the health or the life of a patient. 相似文献
13.
Tolerance of ocular iontophoresis in healthy volunteers. 总被引:4,自引:0,他引:4
Thomas M Parkinson Elizabeth Ferguson Salvatore Febbraro Arash Bakhtyari Martin King Mohan Mundasad 《Journal of ocular pharmacology and therapeutics》2003,19(2):145-151
To evaluate ocular tolerance, healthy volunteers were iontophoresed transclerally using novel OcuPhor trade mark hydrogel drug delivery applicators filled with balanced salt solution. In this three-period crossover study in 24 male and female subjects, 16 subjects received 0 mA and two of the following DC currents: 0.1, 0.5., 1.0, 2.0, 3.0, or 4.0 mA for 20 min; 6 subjects received 3 mA for 20 min and 1.5 mA for 40 min (both equivalent to 60 mAmin total charge). Safety and tolerance were determined by subjective VAS and objective ophthalmic assessments. Subjects were evaluated before and up to 22 hr after dosing. The applicators were well-tolerated and no clinically significant changes in symptomology or in ophthalmic assessments were seen following exposure to 0-3.0 mA for 20 min or 1.5 mA for 40 min. At 4.0 mA 2 of 4 subjects reported a burning sensation under the applicator during dosing which resolved by 22 hr post-dose; superficial changes in fluorescein staining were observed at 1 hr, but not at 22 hr. The OcuPhor trade mark system has promise for noninvasive drug delivery to the eye. 相似文献
14.
15.
Alice H.M. Beare PhD ; Stephen M. Krane MD ; Mark W.J. Ferguson DDS PhD 《Wound repair and regeneration》2005,13(1):27-40
Collagen undergoes dramatic reorganization during wound repair. Matrix metalloproteinases degrade and remodel collagen in a tightly controlled process. The collagenase-resistant mouse, Col1a1(tm1Jae), produces type I collagen, which is resistant to degradation by human matrix metalloproteinase 1. These mice grow normally but develop thickened skin with age. We have previously reported that the early wound repair response in homozygous mutant (Col1a1(r/r)) mice is delayed compared to wild type (Col1a1(+/+)). However, the late-stage scar of Col1a1(r/r) wounds was not significantly altered compared to Col1a1(+/+). Here we have investigated the response of heterozygous mice (Col1a1(+/r)) to wounding, not previously reported. Wound reepithelialization was delayed to a similar degree to wounds in the Col1a1(r/r) mice. However, the recovery of impaired wound contraction was faster in Col1a1(+/r) than in Col1a1(r/r) mice, but still slower than in wild-type animals. Analysis of wound protein extracts showed expression of some matrix metalloproteinases was prolonged in both the Col1a1(r/r) and Col1a1(+/r) wounds compared to wild type. We suggest the partial resistance of collagen to collagenase-mediated degradation in the heterozygous animals causes equivalent impairment of keratinocyte migration compared to homozygous collagenase-resistant mice, but that wound contraction during late-stage healing is only partially retarded. 相似文献
16.
S. A. R. Nouraei C. B. Singh M. S. Ferguson K. Young D. Roy J. M. Philpott 《European journal of plastic surgery》2007,30(4):153-157
The objective of this study is to assess the results of repairing septal perforations with a vascularized pedicled alar cartilage
island flap. Using the external rhinoplasty approach, a vascularized flap of alar cartilage, harvested as a cephalic trim
and pedicled on the ascending columellar branches of the superior labial artery was raised. Bilateral mucoperichondrial septal
flaps were elevated and the alar flap was transposed and secured within the defect and bilaterally overlaid with temporalis
fascia. Silastic sheets were placed and remained in situ until the grafts were revascularized from the peripheries of the
defect as well as centrally from the alar flap. The revascularized temporalis fascia acted as a scaffold for nasal remucosalization.
The alar flap also increased the long-term structural robustness of the repair. Between 1999 and 2003, 14 patients with septal
perforations ranging from 10 to 31 mm underwent septal reconstruction using this technique. There were nine males and five
females. The flap was successfully raised in all cases and long-term closure was maintained in 12 patients (86%). The alar
cartilage flap is an effective technique for repairing septal perforations in selected patients. It provides vascularized
tissue which nourishes the grafts during remucosalization, and a cartilaginous framework, which affords long-term structural
support to the repair. It also obviates the need to transpose nasal mucosa and create a secondary defect. The rhinoplasty
approach furthermore permits additional nasal deformities to be corrected at the same time.
Presented at the British Association of Plastic Surgeons Summer Scientific Meeting, Sheffield, UK (12 July 2006). 相似文献
17.
"RSI": putting the epidemic to rest 总被引:4,自引:0,他引:4
D A Ferguson 《The Medical journal of Australia》1987,147(5):213-214
18.
Ohne Zusammenfassung 相似文献
19.
BACKGROUND--Previous studies have shown poor compliance with regular drug therapy in children and adults with asthma. In preschool children the parents supervise and are responsible for drug administration, but little is known of compliance in this group. In addition, there are few data on the patterns of drug use of inhaled prophylactic asthma therapy or of the relation between compliance and symptom control. A study was undertaken to address these issues with the hypothesis that parental supervision would result in good compliance. METHODS--The subjects were 29 asthmatic children aged 15 months to five years already established on inhaled prophylactic medication delivered through a large volume spacer. The prescribed drug regimens varied between subjects. This was an observational study using an electronic inhaler timer device to record the date and time of each actuation of the aerosol canister. Diary cards were used for parallel recording of symptoms and parentally reported compliance with a drug regimen. RESULTS--Variable and generally poor compliance was demonstrated with a median of 50% of study days with full compliance (subject range 0-94%) and an overall median of 77% of prescribed doses of therapy taken during the study period. No relation was found between frequency of prescribed regimen and good compliance. Day care was associated with poorer compliance. No relation between good compliance and low symptom scores was found. CONCLUSION--Compliance with inhaled prophylactic therapy is poor in preschool children with asthma whose medication is administered under parental supervision. 相似文献
20.
Both cyproterone acetate (CPA) and the gonadotrophin-releasing hormone
agonist (GnRHa) have been shown to be effective for the treatment of
hirsutism. We wished to compare the effectiveness of CPA in two standard
doses with GnRHa and add-back therapy and to compare the length of
remission after these treatments. A total of 60 hirsute hyperandrogenic
women was assigned to the following treatment groups: CPA 2 mg with 35
microg of ethinylestradiol for 21 days each month (Diane group), CPA 50 mg,
days 5-15, and ethinylestradiol 50 microg, days 5-25, each month (CPA
group) or Decapeptyl 3.75 mg i.m. every 28 days with the addition of
conjugated oestrogen 0.625 mg, days 1-21, and medroxyprogesterone acetate
10 mg, days 12-21 (GnRHa group). Hirsutism was graded by the
Ferriman-Gallwey-Lorenzo (FGL) index and anagen hair shaft diameters and
serum luteinizing hormone (LH) and testosterone were assessed before and
every 3 months during and after treatment. All women were treated for 1
year with 1 year follow-up. At baseline hirsutism and endocrine patterns
were similar in all groups. After one year of treatment, hirsutism
decreased in all groups but the changes were greater (P <0.05) in the
CPA and GnRHa groups than in the Diane group. Serum LH and testosterone
were lowest in the GnRHa group. After withdrawal, hirsutism increased
rapidly in the Diane and CPA groups and after 6 months, FGL scores and hair
shaft diameters were similar to pretreatment values. In the GnRHa group,
hirsutism increased more gradually and after 1 year of withdrawal, FGL
scores and hair diameters were significantly (P <0.05) less than
pretreatment values. Serum LH and testosterone increased rapidly in all
three groups reaching pretreatment values by 6 months. These data suggest
equal efficacy of the GnRHa and the high dose CPA regimen for the treatment
of hirsutism in hyperandrogenic women. GnRHa with add-back treatment
appears to result in a longer remission of hirsutism in comparison with
CPA.
相似文献